Single Agents in Cancer Chemotherapy

[1]  M. Walker,et al.  BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report. , 1970, Cancer chemotherapy reports.

[2]  C. Pratt,et al.  Intrathecal arabinosyl cytosine in meningeal leukemia , 1970, Cancer.

[3]  T. Vietti,et al.  Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission , 1970, Cancer.

[4]  I. Ariel.  Therapeutic effects of hydroxyurea. Experience with 118 patients with inoperable solid tumors , 1970, Cancer.

[5]  Fink Dj,et al.  6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study. , 1970 .

[6]  D. Karnofsky,et al.  Toxicity of E. coli L‐asparaginase in man , 1970, Cancer.

[7]  E. Henderson,et al.  L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia. , 1970, Cancer chemotherapy reports.

[8]  D. Karnofsky,et al.  E. coli L‐asparaginase in the treatment of leukemia and solid tumors in 131 children , 1970, Cancer.

[9]  R. Hahn,et al.  Oral methotrexate therapy of gastrointestinal carcinoma. , 1970, Surgery, gynecology & obstetrics.

[10]  D. Karnofsky,et al.  Clinical results of treatment with E. coli L‐asparaginase in adults with leukemia, lymphoma, and solid tumors , 1970, Cancer.

[11]  G. Bodey,et al.  Prolonged infusion of arabinosyl cytosine in childhood leukemia , 1970, Cancer.

[12]  E. Humphrey.  Therapy for carcinoma of the lung. , 1970, Minnesota medicine.

[13]  W. G. Thurman,et al.  Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388). , 1970, Cancer chemotherapy reports.

[14]  W. Kreis.  Metabolism of an antineoplastic methylhydrazine derivative in a P815 mouse neoplasm. , 1970, Cancer research.

[15]  G. Bryan,et al.  Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man. , 1969, Cancer research.

[16]  L. Sadoff.  Effects of Streptozotocin in a Patient with Islet Cell Carcinoma , 1969, Diabetes.

[17]  Yung-Sheng Cheng,et al.  METHOTREXATE THERAPY IN TROPHOBLASTIC DISEASE AT THE PROVINCIAL TAIPEI HOSPITAL (1955–1966) , 1969 .

[18]  G. Bonadonna,et al.  Comparative effects of vinblastine and procarbazine in advanced Hodgkin's disease. , 1969, European journal of cancer.

[19]  G. Ramírez,et al.  Low doses of vincristine (NSC-67574) for malignant disease. , 1969, Cancer chemotherapy reports.

[20]  J. Bickers,et al.  Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). , 1969, Cancer research.

[21]  C. Wilson,et al.  Brain tumor chemotherapy with intrathecal methotrexate , 1969, Cancer.

[22]  G. Ramírez,et al.  A ten-year study of 5-flurouracil in disseminated breast cancer with clinical results and survival times.. , 1969, Cancer research.

[23]  G. Bonadonna,et al.  Cardiac toxicity of daunorubicin. , 1969, Lancet.

[24]  J. Malpas,et al.  Daunorubicin in acute myelocytic leukaemia. , 1969, Lancet.

[25]  L. Massimo,et al.  Vincristine plus vinblastine in acute childhood leukaemia. , 1969, Lancet.

[26]  M. Boiron,et al.  Daunorubicin in the treatment of acute myelocytic leukaemia. , 1969, Lancet.

[27]  E. Freireich,et al.  Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults. , 1969, Cancer chemotherapy reports.

[28]  R. Raskind,et al.  Treatment of malignant brain tumors by local methotrexate. A preliminary report. , 1969, International surgery.

[29]  M. Brennan,et al.  Treatment of metastatic hypernephroma. , 1969, JAMA.

[30]  J. Adamson,et al.  The effect of daunomycin on human cells in vivo and in vitro , 1969, Cancer.

[31]  S. Malawista,et al.  MICROTUBULAR CRYSTALS IN MAMMALIAN CELLS , 1969, The Journal of cell biology.

[32]  H. Hope‐Stone.  The treatment of the reticuloses. , 1969, The British journal of radiology.

[33]  F. Muggia,et al.  Treatment of advanced Hodgkin's disease with vinblastine (NSC-49842) or procarbazine (NSC-77213). , 1969, Cancer chemotherapy reports.

[34]  M. Samuels,et al.  Procarbazine (NSC-77213) in the treatment of advanced bronchogenic carcinoma. , 1969, Cancer chemotherapy reports.

[35]  R. Hahn,et al.  Comparative response of carcinoma of the rectum and carcinoma of the colon to fluorinated pyrimidine therapy. , 1969, Cancer chemotherapy reports.

[36]  H. Lerner,et al.  Hydroxyurea (NSC-32065) intermittent therapy in malignant diseases. , 1969, Cancer chemotherapy reports.

[37]  C. Smart,et al.  Clinical experience with vincristine (NSC-67574) in tumors of the central nervous system and other malignant diseases. , 1968, Cancer chemotherapy reports.

[38]  H. Madoc‐Jones,et al.  Interphase action of vinblastine and vincristine: Differences in their lethal action through the mitotic cycle of cultured mammalian cells , 1968, Journal of cellular physiology.

[39]  T. Hall,et al.  Chemotherapy with hydroxyurea (NSC-32065) in renal cell carcinoma. , 1968, The Journal of clinical pharmacology and the journal of new drugs.

[40]  J. Luce,et al.  Treatment of cancer with weekly intravenous 5‐fluorouracil , 1968, Cancer.

[41]  T. Vietti,et al.  Clinical study of daunomycin (NSC‐82151) in children with acute leukemia , 1968, Cancer.

[42]  A. Eddleston,et al.  Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. , 1968, Lancet.

[43]  D. Herbert,et al.  A new L-asparaginase with antitumour activity? , 1968, Lancet.

[44]  J. Furth,et al.  Inhibition of Mammalian DNA Polymerase by the 5′-Triphosphate of 1-β-d-Arabinofuranosylcytosine and the 5′-Triphosphate of 9-β-d-Arabinofuranosyladenine , 1968 .

[45]  D. Hammond,et al.  Induction of remission in acute leukemia with prednisone and intravenous methotrexate. , 1968, The Journal of pediatrics.

[46]  C. Spurr,et al.  Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. , 1968, Blood.

[47]  R. Adamson,et al.  Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review. , 1968, Cancer chemotherapy reports.

[48]  R. Ausman,et al.  Effects of 6-mercaptopurine (NSC-755) in 290 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. , 1968, Cancer chemotherapy reports.

[49]  J. Couture.  Intra-arterial infusion therapy for oral cancer. , 1968, Canadian journal of surgery. Journal canadien de chirurgie.

[50]  I. Wodinsky,et al.  On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA. , 1968, Cancer research.

[51]  R. Hahn,et al.  Therapy of advanced gastrointestinal cancer with 1‐3‐bis‐(2‐chlorethyl)‐l‐nitrosourea (BCNU) , 1968, Clinical pharmacology and therapeutics.

[52]  P. Reichard,et al.  Inhibition of ribonucleoside diphosphate reductase by hydroxyurea. , 1968, Cancer research.

[53]  E. Ezdinli,et al.  Vinblastine VS. nitrogen mustard therapy of Hodgkin's disease , 1968, Cancer.

[54]  M. Haggard,et al.  Vincristine in acute leukemia of childhood , 1968, Cancer.

[55]  H. Lessner,et al.  BCNU (1,3), BIS(B‐chloroethyl)‐1‐nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia , 1968, Cancer.

[56]  J. Malpas,et al.  Rubidomycin in Acute Leukaemia in Adults , 1968, British medical journal.

[57]  J. Wolter,et al.  Mithramycin therapy in disseminated germinal testicular cancer. , 1968, JAMA.

[58]  A. Akashi,et al.  Further investigation on the carcinostatic activity of 4(or 5)-aminoimidazole-5(or 4)-carboxamide derivatives: structure-activity relationship. , 1968, Gan.

[59]  H. Levin,et al.  Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program. , 1968, JAMA.

[60]  C. Spurr,et al.  Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. , 1968, Cancer research.

[61]  V. Rege,et al.  Treatment of carcinoma of the head and neck with intravenous methotrexate , 1968, Cancer.

[62]  B. Dvorkin,et al.  Influence of cortisol on the utilization of precursors of nucleic acids and protein by lymphoid cells in vitro. , 1968, The Journal of biological chemistry.

[63]  D. Decker,et al.  Observations on gynecologic malignancy treated with 5-fluorouracil. , 1968, American journal of obstetrics and gynecology.

[64]  T. Hall,et al.  Comparison of methotrexate (NSC-740) and testosterone propionate (NSC-9166) in the treatment of breast cancer. , 1968, The Journal of clinical pharmacology and the journal of new drugs.

[65]  J. Wolff,et al.  Varying prednisone dosage in remission induction of previously untreated childhood leukemia , 1968, Cancer.

[66]  W. Newton,et al.  Cytosine arabinoside: Results of a cooperative study in acute childhood leukemia , 1968, Cancer.

[67]  W. S. Walsh,et al.  Hydroxyurea (NSC-32065) in therapy for nonresectable cancer of the lung. , 1968, Cancer chemotherapy reports.

[68]  W. Newton,et al.  Intrathecal methotrexate (NSC-740) therapy for brain tumors in children. , 1968, Cancer chemotherapy reports.

[69]  H. S. Schwartz,et al.  Actinomycin D: drug concentrations and actions in mouse tissues and tumors. , 1968, Cancer research.

[70]  W. Vogler,et al.  Methotrexate for advanced cancer of the breast , 1968, Cancer.

[71]  W. Creasey.  Effect of the vinca alkaloids on rna synthesis in relation to mitotic arrest. Abstr. , 1968 .

[72]  I. Wodinsky,et al.  Uptake in vivo and in vitro of actinomycin D by mouse leukemias as factors in survival. , 1968, Biochemical pharmacology.

[73]  W. Silliphant,et al.  Trophoblastic tumors of the uterus-problems of methotrexate therapy. , 1968, California medicine.

[74]  W. Sutow.  Vincristine (NSC-67574) therapy for malignant solid tumors in children (except Wilms' tumor). , 1968, Cancer chemotherapy reports.

[75]  M. Hreshchyshyn.  Hydroxyurea (NSC-32065) with irradiation for cervical carcinoma--preliminary report. , 1968, Cancer chemotherapy reports.

[76]  J. Holland,et al.  Effect of vincristine (NSC-67574) on malignant solid tumors in children. , 1968, Cancer chemotherapy reports.

[77]  I. Djerassi.  Methotrexate infusions and intensive supportive care in the management of children with acute lymphocytic leukemia: follow-up report. , 1967, Cancer research.

[78]  J. H. Kim,et al.  Inhibition of leukemias in man by L-asparaginase. , 1967, Cancer research.

[79]  P. Schein,et al.  The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. , 1967, Cancer research.

[80]  J. Bernard.  Acute leukemia treatment. , 1967, Cancer research.

[81]  A. Akashi,et al.  Pharmacological studies on 4 (or 5)-aminoimidazole-5 (or 4)-carboxamide (AICA) derivatives. , 1967, Japanese journal of pharmacology.

[82]  Wyatt Jk,et al.  A chemotherapeutic approach to advanced testicular carcinoma. , 1967 .

[83]  P. Cassileth,et al.  Treatment of malignant melanoma with hydroxyurea. , 1967, Cancer research.

[84]  R. Oberfield,et al.  Re-evaluation of methotrexate as an anticancer drug. , 1967, Surgery, gynecology & obstetrics.

[85]  J. Bertino,et al.  Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas. , 1967, Cancer chemotherapy reports.

[86]  S. Eckhardt,et al.  Metabolic pathway of cytostatic dibromohexitols. , 1967, Cancer chemotherapy reports.

[87]  F. Moore,et al.  Carcinoma of the breast. A decade of new results with old concepts. , 1967, The New England journal of medicine.

[88]  R. M. Hardisty,et al.  Meningeal leukaemia. , 1967, Archives of disease in childhood.

[89]  R. Rundles,et al.  Comparison of methotrexate with 6‐mercaptopurine–prednisone in treatment of acute leukemia in adults , 1967, Cancer.

[90]  E. Frei,et al.  Clinical trials with N‐isopropyl‐α‐(2‐methylhydrazino)‐p‐toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia , 1967, Cancer.

[91]  A. Watne,et al.  Solid tumor chemotherapy with mitomycin C. , 1967, Archives of surgery.

[92]  C. Wilson,et al.  Brain tumor chemotherapy with methotrexate given intrathecally. A new technique. , 1967, JAMA.

[93]  L. Old,et al.  Treatment of lymphosarcoma in the dog with L‐asparaginase , 1967, Cancer.

[94]  W. Whitmore,et al.  Mithramycin in metastatic urogenital cancer. , 1967, The Journal of urology.

[95]  H. Skipper,et al.  Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. , 1967, Cancer chemotherapy reports.

[96]  S. Salmon,et al.  Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. , 1967, Cancer chemotherapy reports.

[97]  T. Hall,et al.  High-dose corticoid therapy in Hodgkin's disease and other lymphomas. , 1967, Annals of internal medicine.

[98]  E. Csanyi,et al.  Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma. , 1967, British Journal of Cancer.

[99]  A. Stacher,et al.  [On the effect of a new cytostatic agent (Myelobromol) in chronic myeloid leukemias]. , 1967, Wiener medizinische Wochenschrift.

[100]  S. Cohen,et al.  Effects of arabinonucleotides on ribonucleotide reduction by an enzyme system from rat tumor. , 1967, The Journal of biological chemistry.

[101]  G. Ross,et al.  Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms. , 1967, American journal of obstetrics and gynecology.

[102]  G. Petrányi,et al.  [Treatment of chronic myeloid leukemia with Myelobromol]. , 1967, Orvosi hetilap.

[103]  J. Bertino,et al.  Methotrexate (NSC-740) in squamous cell carcinoma of the head and neck. II. Intermittent intravenous therapy. , 1967, Cancer chemotherapy reports.

[104]  J. Wolff,et al.  Prednisone therapy of acute childhood leukemia: prognosis and duration of response in 330 treated patients. , 1967, The Journal of pediatrics.

[105]  Roy Dk.  Treatment of advanced or recurrent carcinoma of the cervix by cytotoxic drugs. , 1967 .

[106]  L. Old,et al.  Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity. , 1967, Biochemistry.

[107]  L. Old,et al.  SUPPRESSION OF MURINE LEUKEMIAS BY L-ASPARAGINASE , 1967, The Journal of experimental medicine.

[108]  A. Argoudelis,et al.  The structure of streptozotocin. , 1967, Journal of the American Chemical Society.

[109]  A. Postel,et al.  Induced remission of malignant melanoma with actinomycin D. Immunologic implications , 1967, Cancer.

[110]  D. Karnofsky,et al.  Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia , 1967, Cancer.

[111]  H. Hertz,et al.  Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease. , 2009, Acta medica Scandinavica.

[112]  M. Turner,et al.  Meso-α,β-diphenylsuccinate and Hydroxyurea as Inhibitors of Deoxycytidylate Synthesis in Extracts of Ehrlich Ascites and L Cells , 1966 .

[113]  R. Ausman,et al.  Is toxicity really necessary? I. The question , 1966, Cancer.

[114]  N. Mantel,et al.  Eradication Of Leukaemic Cells (L1210) by Methotrexate and Methotrexate Plus Citrovorum Factor , 1966, Nature.

[115]  J. Szentkláray.  [Treatment of polycythemia vera with Myelobromol]. , 1966, Orvosi hetilap.

[116]  Jerome R. Klinobeil.  Infusion chemotherapy in head and neck tumors , 1966 .

[117]  L. Laufe,et al.  Infusion Through Inferior Gluteal Artery for Pelvic Cancer: A Preliminary Report , 1966, Obstetrics and gynecology.

[118]  A. Mackenzie.  Chemotherapy of metastatic testis cancer: Results in 154 patients , 1966, Cancer.

[119]  L. Mashburn,et al.  Change in Ribonuclease Concentrations in L-Asparaginase-treated Lymphosarcomata , 1966, Nature.

[120]  J. Bateman,et al.  Advanced carcinoma of the cervix treated by intra-arterial methotrexate. , 1966, American journal of obstetrics and gynecology.

[121]  J. Cortner,et al.  Central nervous system leukemia and solid tumors of childhood: Treatment with 1,3‐bis (2‐chloroethyl)‐1‐nitrosourea (BCNU) , 1966, Cancer.

[122]  M. N. Silverstein,et al.  Anaerobic glycolysis in normal and leukemic bone‐marrow leukocytes: Effect of methyl‐glyoxal‐bis‐guanylhydrazone dihydrochloride , 1966, Cancer.

[123]  L. Lassman,et al.  Effect of vincristine sulphate on the intracranial gliomata of hildhood , 1966, The British journal of surgery.

[124]  W. J. Yount,et al.  Treatment of refractory reticulum cell sarcoma with low doses of vincristine sulfate. , 1966, JAMA.

[125]  R. Scott,et al.  Chemotherapy of Hodgkin's Disease with Cyclophosphamide, Vinblastine, and Procarbazine , 1966, British medical journal.

[126]  A. Ommaya,et al.  Cerebrospinal fluid perfusion for central nervous system neoplasms , 1966, Neurology.

[127]  C. Griffiths,et al.  Time and vehicle studies of a safe and effective method for administration of 5‐fluorouracil , 1966, Cancer.

[128]  V. Devita,et al.  Preliminary clinical studies with ibenzmethyzin , 1966, Clinical pharmacology and therapeutics.

[129]  A. Sartorelli,et al.  Studies on the biochemical mode of action of a cytotoxic methylhydrazine derivative, N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide. , 1966, Molecular pharmacology.

[130]  M. Murphy,et al.  Cytosine arabinoside (NSC-63878) in acute leukemia in children. , 1966, Cancer chemotherapy reports.

[131]  W. Krivit,et al.  Induction of remission in acute leukemia of childhood by combination of prednisone and either 6-mercaptopurine or methotrexate. , 1966, The Journal of pediatrics.

[132]  Yiming Li,et al.  A trial of vinblastine sulphate in the treatment of inoperable carcinoma of the lung. , 1966, British Journal of Cancer.

[133]  K. Narayan,et al.  Effects of actinomycin D on base composition and nearest neighbor frequency of nucleolar RNA of the Walker tumor and liver. , 1966, Cancer research.

[134]  B. Hoogstraten,et al.  The role of vincristine in the treatment of childhood acute leukemia , 1966, Clinical pharmacology and therapeutics.

[135]  Y. Shealy,et al.  Complete Inhibition of Mouse Leukaemia L1210 by 5(or 4)-[3,3-Mbis (2-Chloroethyl)-l-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196) , 1966, Nature.

[136]  R. Sellwood,et al.  Cancer chemotherapy by continuous intra‐arterial infusion of methotrexate , 1966, The British journal of surgery.

[137]  H. Lerner,et al.  Hydroxyurea in bladder carcinoma. , 1966, Investigative urology.

[138]  J. D. Smedt,et al.  Action du Natulan dans 94 cas de tumeurs solides , 1966 .

[139]  W. H. Bond,et al.  Treatment of neoplastic diseases with an improved oral preparation of vinblastine sulfate , 1966, Cancer.

[140]  J. Bertino,et al.  Sequential chemotherapy and radiotherapy. Preliminary results of clinical trial with methotrexate in head and neck cancer. , 1966, Radiology.

[141]  E. Ezdinli,et al.  Vinblastine sulfate vs cyclophosphamide in the therapy for lymphoma. , 1966, JAMA.

[142]  T. Backhouse,et al.  Initial experiences with methylhydrazine, a new cytotoxic agent. , 1966, Clinical radiology.

[143]  W. Szybalski,et al.  Physicochemical properties of complexes between deoxyribonucleic acid and antibiotics which affect ribonucleic acid synthesis (actinomycin, daunomycin, cinerubin, nogalamycin, chormomycin, mithramycin, and olivomycin). , 1966, Biochemistry.

[144]  V. Ujházy,et al.  Clinical application of myelobromol in chronic myeloses. , 1966, Neoplasma.

[145]  H. Schell,et al.  5-Fluorouracil (NSC-19893) in glucose and saline: therapeutic effect and toxicity. , 1966, Cancer chemotherapy reports.

[146]  J. DiPaolo,et al.  The antimitochondrial action of 2-choloro-4', 4"-bis(2-imidazolin-2-yl)terephthalanilide and methylglyoxal bis(guanylhydrazone). , 1966, Cancer research.

[147]  L. Institóris,et al.  Comparative data on the action mechanism of 1,6-dibromo-1,6-dideoxy-D-mannitol and 1,4-dimethanesulfonyloxy-n-butane. , 1966, Arzneimittel-Forschung.

[148]  H. Snyman,et al.  Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas. , 1966, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[149]  R. Hahn,et al.  Evaluation of hydroxyurea (NSC-32065) by parenteral infusion. , 1965, Cancer chemotherapy reports.

[150]  B. Kennedy,et al.  Effect of androgenic hormone combined with hydroxyurea (NSC-32065) on hematopoietic system of patients with cancer. , 1965, Cancer chemotherapy reports.

[151]  C. Hodgkinson,et al.  Prolonged intra‐arterial therapy for advanced pelvic malignancy , 1965, Cancer.

[152]  D. Kessel,et al.  Uptake as a Determinant of Methotrexate Response in Mouse Leukemias , 1965, Science.

[153]  H. Wilson,et al.  The Use of Low Dosage Drug Regimens in the Treatments of Neoplastic Disease. , 1965 .

[154]  V. Vaitkevicius,et al.  Comparison of cyclophosphamide and 5‐fluorouracil in the treatment of patients with metastatic breast cancer , 1965, Clinical pharmacology and therapeutics.

[155]  G. P. Wheeler,et al.  Some effects of 1, 3-bis(2-chloroethyl)-1-nitrosourea upon the synthesis of protein and nucleic acids in vivo and in vitro. , 1965, Cancer research.

[156]  H. Lerner,et al.  Hydroxyurea (NSC-32065) in biologic fluids: dose-concentration relationship. , 1965, Cancer chemotherapy reports.

[157]  T. Soper,et al.  Intra-arterial infusion of streptonigrin (NSC-45383) in advanced cancer. , 1965, Cancer chemotherapy reports.

[158]  G. Ross,et al.  SEQUENTIAL USE OF METHOTREXATE AND ACTINOMYCIN D IN THE TREATMENT OF METASTATIC CHORIOCARCINOMA AND RELATED TROPHOBLASTIC DISEASES IN WOMEN. , 1965, American journal of obstetrics and gynecology.

[159]  K. Brunner,et al.  A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS. , 1965, Annals of internal medicine.

[160]  H. Lerner,et al.  HYDROXYUREA ADMINISTERED INTERMITTENTLY. , 1965, JAMA.

[161]  I. H. Mannheimer.  Hypercalcemia of breast cancer. management with corticosteroids , 1965, Cancer.

[162]  N. Bleehen,et al.  Vinblastine Sulphate in the Treatment of Malignant Disease , 1965, British Journal of Cancer.

[163]  M. Hakala.  On the role of drug penetration in amethopterin resistance of Sarcoma-180 cells in vitro. , 1965, Biochimica et biophysica acta.

[164]  J. Bertino,et al.  COMPLEX FORMATION WITH DNA AND INHIBITION OF NUCLEIC ACID SYNTHESIS BY METHYLGLYOXAL BIS(GUANYLHYDRAZONE). , 1965, Biochimica et biophysica acta.

[165]  S. McCracken,et al.  CONTINUOUS INTRAVENOUS INFUSION OF STREPTONIGRIN (NSC-45383) IN PATIENTS WITH BRONCHOGENIC CARCINOMA. , 1965, Cancer chemotherapy reports.

[166]  M. Lipsett,et al.  Chemotherapy in women with trophoblastic disease: Choriocarcinoma, chorioadenoma destruens, and complicated hydatidiform mole , 1965, Wisconsin medical journal.

[167]  T. Nemoto,et al.  VINCRISTINE (NSC-67574): DOSAGE AND RESPONSE IN ADVANCED BREAST CANCER. , 1965, Cancer chemotherapy reports.

[168]  D. Wright,et al.  The African lymphoma: Preliminary observations on response to therapy , 1965, Cancer.

[169]  N. Ruderman,et al.  Use of glucocorticoids in the palliative treatment of metastatic brain tumors , 1965, Cancer.

[170]  W. Vogler,et al.  TOXICITY AND ANTITUMOR EFFECT OF DIVIDED DOSES OF METHOTREXATE. , 1965, Archives of internal medicine.

[171]  R. Baker,et al.  REGIONAL ARTERIAL INFUSION OF ANTIMETABOLITES. AN ANALYSIS OF THE RESULTS OBTAINED IN 33 PATIENTS WITH MALIGNANT TUMORS OF THE HEAD AND NECK. , 1965, The Journal of surgical research.

[172]  G. Pearce,et al.  SENSITIVITY OF INTRACRANIAL GLIOMAS TO VINCRISTINE SULPHATE. , 1965, Lancet.

[173]  C. Griscelli,et al.  N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213) IN TREATMENT OF SOLID TUMORS. , 1965, Cancer chemotherapy reports.

[174]  M. Harris,et al.  Chemotherapy with streptonigrin in advanced cancer , 1965 .

[175]  R. H. Levin,et al.  Treatment of acute leukemia with methylglyoxal‐bis‐guanylhydrazone (methyl GAG) , 1965, Clinical pharmacology and therapeutics.

[176]  F. Ansfield.  Clinical trial of vinblastine (NSC-49842) in colo-rectal cancer. , 1965, Cancer chemotherapy reports.

[177]  F. Rosner,et al.  BREAST CANCER: COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH. , 1965, Annals of internal medicine.

[178]  C. Smart,et al.  CHEMOTHERAPY OF MALIGNANCIES OF THE GASTROINTESTINAL TRACT. , 1965, American journal of surgery.

[179]  J. S. Góis,et al.  [Chemotherapy of breast cancer]. , 1965, Revista de ginecologia e d'obstetricia.

[180]  A. J. Howard,et al.  Effect of compounds with both antitumor and bacteriophage-inducing activities on Escherichia coli nucleic acid synthesis. , 1965, Antimicrobial agents and chemotherapy.

[181]  New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. Acute leukemia group B. , 1965, JAMA.

[182]  T. Vietti,et al.  THE RESPONSE OF ACUTE CHILDHOOD LEUKEMIA TO AN INITIAL AND A SECOND COURSE OF PREDNISONE. , 1965, The Journal of pediatrics.

[183]  R. Nissen-Meyer.  ENDOCRINE TREATMENT OF BREAST CANCER. , 1966, Acta - Unio Internationalis Contra Cancrum.

[184]  C. Young,et al.  Hydroxyurea: Inhibitory Effect on DNA Metabolism , 1964, Science.

[185]  F. Ansfield.  A LESS TOXIC FLUOROURACIL DOSAGE SCHEDULE. , 1964, JAMA.

[186]  J. Skom,et al.  CHEMOTHERAPY IN TROPHOBLASTIC DISEASES. , 1964, American journal of obstetrics and gynecology.

[187]  Hreschchyshyn Mm.  EXPERIENCES WITH CHEMOTHERAPY IN GYNECOLOGIC CANCER. , 1964 .

[188]  G. Williams,et al.  METHOTREXATE AND RADIATION IN THE TREATMENT OF PATIENTS WITH CANCER. , 1964, Cancer research.

[189]  E. Freireich,et al.  Clinical trials of hydroxyurea in patients with cancer and leukemia , 1964, Clinical pharmacology and therapeutics.

[190]  T. Haddy,et al.  VINCRISTINE (NSC-67574) IN UNCOMMON MALIGNANT DISEASE IN CHILDREN. , 1964, Cancer chemotherapy reports.

[191]  G. P. Wheeler,et al.  STUDIES WITH MUSTARDS. VI. EFFECTS OF ALKYLATING AGENTS UPON NUCLEIC ACID SYNTHESIS IN BILATERALLY GROWN SENSITIVE AND RESISTANT TUMORS. , 1964, Cancer research.

[192]  Griffith Km.  HYDROXYUREA (NSC-32065): RESULTS OF A PHASE I STUDY. , 1964 .

[193]  Fernbach Dj.  PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065). , 1964 .

[194]  G. Owens,et al.  CHEMOTHERAPY OF PRIMARY GLIOMAS OF THE BRAIN. , 1964, New York state journal of medicine.

[195]  P. Davis.  PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA. , 1964, Cancer chemotherapy reports.

[196]  M. Murphy,et al.  PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION. , 1964, Cancer chemotherapy reports.

[197]  C. E. Wilde,et al.  INFUSION THERAPY FOR PELVIC TROPHOBLASTIC TUMOURS , 1964, The Journal of obstetrics and gynaecology of the British Commonwealth.

[198]  Bolton Bh,et al.  HYDROXYUREA (NSC-32065)--A PHASE I STUDY. , 1964 .

[199]  R. J. Feder,et al.  CONTINUOUS INTRA-ARTERIAL INFUSION OF METHOTREXATE FOR RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK. , 1964, The American surgeon.

[200]  J. White,et al.  "HISTIOCYTOSIS X" TREATED WITH VINBLASTINE SULFATE (NSC-49842). , 1964, Cancer chemotherapy reports.

[201]  J. Meredith,et al.  REGIONAL ARTERIAL INFUSION FOR LOCALIZED MALIGNANCIES. , 1964, Archives of surgery.

[202]  S. Bellman,et al.  CHEMOTHERAPY OF FIVE SUPRATENTORIAL MALIGNANT GLIOMAS WITH INTRA-ARTERIAL INFUSION OF METHOTREXATE. , 1964, Acta chirurgica Scandinavica.

[203]  L. Mashburn,et al.  TUMOR INHIBITORY EFFECT OF L-ASPARAGINASE FROM ESCHERICHIA COLI. , 1964, Archives of biochemistry and biophysics.

[204]  A. Levine,et al.  Mechanisms of Drug Absorption and Excretion , 1964 .

[205]  R. C. Hickey,et al.  INTRA-ARTERIAL INFUSION FOR HEAD AND NECK CANCER. , 1964, Archives of surgery.

[206]  S. Roath,et al.  THE ACUTE LEUKAEMIAS: A STUDY OF 580 PATIENTS. , 1964, The Quarterly journal of medicine.

[207]  D. Hammond,et al.  TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN. , 1964, Cancer chemotherapy reports.

[208]  P. Magee,et al.  Cellular injury and carcinogenesis. Alkylation of ribonucleic acid of rat liver by diethylnitrosamine and n-butylmethylnitrosamine in vivo. , 1964, The Biochemical journal.

[209]  R. Hahn,et al.  FLUORINATED PYRIMIDINE THERAPY OF ADVANCED GASTROINTESTINAL CANCER. , 1964, Gastroenterology.

[210]  Shaw Rk,et al.  METHYLGLYOXAL BIS(GUANYLHYDRAZONE), NSC-32946, 1 IN THE TREATMENT OF ACUTE MYELOBLASTIC AND MONOBLASTIC LEUKEMIA IN ADULTS. , 1964 .

[211]  W. Regelson,et al.  COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER. , 1964, Cancer chemotherapy reports.

[212]  H. Lemon,et al.  REMISSION OF METASTASES OF ERYTHROPOIETIN-SECRETING RENAL CELL ADENOCARCINOMA AFTER 6-MERCAPTOPURINE (NSC-755)-1 THERAPY. , 1964, Cancer chemotherapy reports.

[213]  R. Silvestrini,et al.  ‘Daunomycin’, a New Antibiotic of the Rhodomycin Group , 1964, Nature.

[214]  D. James,et al.  VINCRISTINE IN CHILDREN WITH MALIGNANT SOLID TUMORS. , 1964, The Journal of pediatrics.

[215]  J. A. Bruner,et al.  CLINICAL EVALUATION OF VINCRISTINE (NSC-67574). , 1964, Cancer chemotherapy reports.

[216]  E. Watkins,et al.  CANCER CHEMOTHERAPY BY PROLONGED ARTERIAL INFUSION. , 1964, Surgery, gynecology & obstetrics.

[217]  C. C. Shullenberger.  PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: LEUKEMIA. , 1964, Cancer chemotherapy reports.

[218]  C. Bloedow.  PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS. , 1964, Cancer chemotherapy reports.

[219]  M. Sears.  PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST. , 1964, Cancer chemotherapy reports.

[220]  A. Nahum,et al.  CLINICAL EXPERIENCE WITH VINBLASTINE SULFATE (NSC-49842) IN SQUAMOUS CELL CARCINOMA AND OTHER MALIGNANCIES. , 1964, Cancer chemotherapy reports.

[221]  M. Hreschchyshyn.  EXPERIENCES WITH CHEMOTHERAPY IN GYNECOLOGIC CANCER. , 1964, New York state journal of medicine.

[222]  A. Evans,et al.  CENTRAL NERVOUS SYSTEM COMPLICATIONS OF CHILDREN WITH ACUTE LEUKEMIA. AN EVALUATION OF TREATMENT METHODS. , 1964 .

[223]  C. Moertel,et al.  VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS. , 1964, Cancer chemotherapy reports.

[224]  P. Magee,et al.  METHYLATION OF RIBONUCLEIC ACIDS OF LIVER AND OTHER ORGANS IN DIFFERENT SPECIES TREATED WITH C14- AND H3-DIMETHYLNITROSAMINES IN VIVO. , 1964, Journal of the National Cancer Institute.

[225]  J. Bickers.  PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CARCINOMA OF THE LUNG. , 1964, Cancer chemotherapy reports.

[226]  E. Lamb,et al.  METHOTREXATE THERAPY OF CHORIOCARCINOMA AND ALLIED TUMORS. , 1964, American journal of obstetrics and gynecology.

[227]  M. Samuels,et al.  PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS. , 1964, Cancer chemotherapy reports.

[228]  J. Bertino,et al.  DETERMINATIONS OF THE LEVELS OF SERUM FOLATE IN PATIENTS WITH CARCINOMA OF THE HEAD AND NECK TREATED WITH METHOTREXATE. , 1964, Cancer research.

[229]  G. Martz,et al.  PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213). , 1963, Cancer chemotherapy reports.

[230]  R. D. Sullivan,et al.  CLINICAL EFFECTS OF PROLONGED (CONTINUOUS) INFUSION OF STREPTONIGRIN (NSC-45383) IN ADVANCED CANCER. , 1963, Cancer chemotherapy reports.

[231]  M. Levine,et al.  THE ACTION OF STREPTONIGRIN ON BACTERIAL DNA METABOLISM AND ON INDUCTION OF PHAGE PRODUCTION IN LYSOGENIC BACTERIA. , 1963, Virology.

[232]  N. Compston,et al.  VINCRISTINE SULPHATE IN THE TREATMENT OF LYMPHOMA AND LEUKAEMIA. , 1963, Lancet.

[233]  H. MacMahon,et al.  VINCRISTINE (LEUROCRISTINE) SULFATE IN THE TREATMENT OF CHILDREN WITH METASTATIC WILMS' TUMOR. PEDIATRIC DIVISION, SOUTHWEST CANCER CHEMOTHERAPY GROUP. , 1963, Pediatrics.

[234]  S. Taylor,et al.  EXPERIENCE WITH VINCRISTINE IN SOLID TUMORS. , 1963, Cancer chemotherapy reports.

[235]  A. Evans,et al.  Vincristine in the treatment of acute leukemia in children , 1963, Cancer.

[236]  S. Berkheiser.  Epithelial proliferation of the lung associated with cortisone administration. A pathological and experimental study , 1963, Cancer.

[237]  R. Eisenstein,et al.  MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED CANCER. , 1963, Cancer chemotherapy reports.

[238]  R. W. Brockman.  BIOCHEMICAL ASPECTS OF MERCAPTOPURINE INHBITION AND RESISTANCE. , 1963, Cancer research.

[239]  G. Hitchings,et al.  RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES. , 1963, Cancer research.

[240]  J. Bertino.  THE MECHANISM OF ACTION OF THE FOLATE ANTAGONISTS IN MAN. , 1963, Cancer research.

[241]  I. S. Johnson,et al.  THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS. , 1963, Cancer research.

[242]  W. C. Werkheiser.  THE BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ACTION AND EFFECTS OF THE FOLIC ACID ANTAGONISTS. , 1963, Cancer research.

[243]  B. Stoll.  Corticosteroids in Therapy of Advanced Mammary Cancer , 1963, British medical journal.

[244]  G. Ross,et al.  Primary chemotherapy of nonmetastatic trophoblastic disease in women. , 1963, American journal of obstetrics and gynecology.

[245]  M. Shaw,et al.  The effects of streptonigrin on cultured human leukocytes. , 1963, Proceedings of the National Academy of Sciences of the United States of America.

[246]  J. Broome.  EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS , 1963, The Journal of experimental medicine.

[247]  H. Skipper,et al.  Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia. , 1963, Cancer research.

[248]  K. Brunner,et al.  [Corticosteroid therapy of chronic lymphatic leukemia]. , 1963, Deutsche medizinische Wochenschrift.

[249]  W. C. Levin,et al.  A phase I study of hydroxyurea. , 1963, Cancer chemotherapy reports.

[250]  T. Sterling,et al.  Intravenous methotrexate (amethopterin) therapy in the treatment of acute leukemia. , 1963, Pediatrics.

[251]  B. L. Yollick,et al.  Regional chemotherapy of head and neck tumors by intra-arterial infusion techniques. , 1963, Texas state journal of medicine.

[252]  P. Carbone,et al.  Clinical studies with vincristine. , 1963, Blood.

[253]  T. Dao,et al.  Fluorinated pyrimidines in treatment of breast cancer patients with liver metastases. , 1963, Cancer chemotherapy reports.

[254]  W. Regelson,et al.  Clinical experience with methylglyoxal bis (guanylhydrazone) dihydrochloride: a new agent with clinical activity in acute myelocytic leukemia and the lymphomas. , 1963, Cancer chemotherapy reports.

[255]  P. Carbone,et al.  Clinical trial of vinblastine in multiple myeloma. , 1963, Cancer chemotherapy reports.

[256]  D. B. Tower,et al.  Guinea pig serum L-asparaginase. Properties, purification, and application to determination of asparagine in biological samples. , 1963, The Journal of biological chemistry.

[257]  J. J. Will,et al.  Vinblastine in Neoplastic Disease Midwest Cooperative Chemotherapy Group , 1963 .

[258]  W. N. Bell,et al.  Comparison of 6-Mercaptopurine and Busulfan in Chronic Granulocytic Leukemia , 1963 .

[259]  D. M. Donohue,et al.  SYSTEMIC THERAPY WITH AMETHOPTERIN IN SQUAMOUS CARCINOMA OF THE HEAD AND NECK. , 1963, Cancer chemotherapy reports.

[260]  J. D. Davidson,et al.  A method of analyzing for hydroxyurea in biological fluids. , 1963, Cancer chemotherapy reports.

[261]  J. Glenn,et al.  Chemotherapy of bladder carcinoma with 5-fluorouracil. , 1963, Cancer chemotherapy reports.

[262]  D. Kodlin,et al.  Acute leukemia in the adult male. I. Comparative effect of 6-mercaptopurine and 6-chloropurine. , 1963, Cancer.

[263]  D. Choy,et al.  Experience with 5-fluorouracil in a variety of solid tumors. , 1962, Cancer chemotherapy reports.

[264]  R. Blattner,et al.  Studies of ACTH hydrocortisone, and 6-mercaptopurine in the treatment of children with acute leukemia. , 1962, The Journal of pediatrics.

[265]  J. Holland,et al.  Initial clinical studies with vincristine. , 1962, Cancer chemotherapy reports.

[266]  G BALLA,et al.  The treatment of head and neck malignancies by continuous intra-arterial infusion of methotrexate. , 1962, American journal of surgery.

[267]  R. Kyle,et al.  Large doses of prednisone and prednisolone in the treatment of malignant lymphoproliferative disorders. , 1962, Annals of internal medicine.

[268]  S. Levick,et al.  Treatment of malignant melanoma of the orbit with intra-arterial methotrexate. , 1962, JAMA.

[269]  M. Kapoor,et al.  Initial steps of purine biosynthesis in wheat germ. , 1962, Biochemical and biophysical research communications.

[270]  G. Ross,et al.  Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. , 1962, Cancer research.

[271]  D. Bergsagel,et al.  Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. II. Mitomycin C (NSC-26980). , 1962, Cancer chemotherapy reports.

[272]  A. Mauer,et al.  Evaluation of intravenous amethopterin therapy in acute leukemia. , 1962, The Journal of pediatrics.

[273]  R. D. Sullivan,et al.  The clinical effects of mitomycin C by continuous intravenous administration. , 1962, Cancer chemotherapy reports.

[274]  J. M. Schroeder,et al.  Five years clinical experience with 5-fluorouracil. , 1962, JAMA.

[275]  Ellison Rr.  Experience with fluorinated pyrimidines in adenocarcinoma of the lower intestinal tract. , 1962 .

[276]  Elliot Js.  Treatment of bladder cancer with amethopterin. , 1962 .

[277]  B. Shnider,et al.  Studies on the folic acid vitamins. VII. The effects of large doses of amethopterin in patients with cancer. , 1962, Cancer research.

[278]  J. Montgomery,et al.  Antitumor activity of triazenoimidazoles. , 1962, Biochemical pharmacology.

[279]  E. Shanbrom,et al.  Critical evaluation of massive steroid therapy of acute leukemia. , 1962, New England Journal of Medicine.

[280]  M. Chu,et al.  A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells. , 1962, Biochemical pharmacology.

[281]  J. Bryan,et al.  Clinical experience with vincaleukoblastine in far-advanced Hodgkin's disease and various malignant states. , 1962, Annals of internal medicine.

[282]  J. White,et al.  A clinical study of 5-fluorouracil in a variety of far advanced human malignancies. , 1962, Journal of the National Medical Association.

[283]  J. G. Armstrong,et al.  Hodgkin's disease, carcinoma of the breast, and other tumors treated with vinblastine sulfate. , 1962, Cancer chemotherapy reports.

[284]  P. Magee,et al.  Toxic liver injury and carcinogenesis. Methylation of rat-liver nucleic acids by dimethylnitrosamine in vivo. , 1962, The Biochemical journal.

[285]  Perese Dm,et al.  Chemotherapy of brain tumors by intra-arterial infusion. , 1962 .

[286]  V. Vaitkevicius,et al.  Cytological and clinical observations during vincaleukoblastine therapy of disseminated cancer , 1962, Cancer.

[287]  M. G. Nelson,et al.  Therapy of Acute Leukaemia , 1962, British Journal of Cancer.

[288]  C. Baines,et al.  A preliminary report on the use of 5-fluorouracil in malignant disease. , 1962, Canadian Medical Association journal.

[289]  C. Manahan,et al.  AMETHOPTERIN IN THE TREATMENT OF TROPHOBLASTIC TUMORS , 1962 .

[290]  R. A. Huseby,et al.  The use of methotrexate orally in treatment of squamous cancers of the head and neck. , 1962, Cancer chemotherapy reports.

[291]  W. H. Bond,et al.  Vincaleukoblastine. IV. A summary of two and one-half years' experience in the use of vinblastine. , 1962, Cancer chemotherapy reports.

[292]  R. Hertz.  Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. , 1962, Cancer chemotherapy reports.

[293]  J. Ultmann,et al.  Factors to be considered in the clinical evaluation of a new chemotherapeutic agent (5-fluorouracil). , 1962, Cancer chemotherapy reports.

[294]  R. Mass.  A comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma. , 1962, Cancer chemotherapy reports.

[295]  D. Bergsagel.  Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma. , 1962, Cancer chemotherapy reports.

[296]  P. Calabresi,et al.  Chemotherapy of neoplastic diseases. , 1962, Annual review of medicine.

[297]  C. C. Shullenberger.  Evaluation of the comparative effectiveness of Myleran and 6-MP in the management of patients with chronic myelocytic leukemia. , 1962, Cancer chemotherapy reports.

[298]  B. Hall,et al.  Treatment of far-advanced cancer with 5-fluorouracil, used alone and in combination with irradiation. Incidence and duration of remission and survival-time data in 223 patients. , 1962, Cancer chemotherapy reports.

[299]  C. C. Shullenberger.  Long-rangetreatment of polycythemia vera with 6-mercaptopurine. , 1962, Cancer chemotherapy reports.

[300]  F. Ansfield,et al.  Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in the treatment of far-advanced breast and colon lesions. , 1962, Cancer chemotherapy reports.

[301]  R. C. Eyerly.  The effects of 5-fluorouracil in patients with incurable cancer. , 1962, Cancer chemotherapy reports.

[302]  J. M. Hill,et al.  Treatment of leukemia, lymphoma, and other malignant neoplasms with Vinblastine. , 1961, Cancer chemotherapy reports.

[303]  L. Carey,et al.  Treatment of advanced cancer of the gastrointestinal tract with antitumor agents. , 1961, Gastroenterology.

[304]  R. Ausman,et al.  An evaluation of actinomycin D and mitomycin C in patients with advanced cancer. , 1961, Surgery.

[305]  A. Weiss,et al.  An evaluation of 5-fluorouracil in malignant disease. , 1961, Annals of internal medicine.

[306]  Allaire Fj,et al.  Cancer chemotherapy with 5-fluorouracil alone and in combination with x-ray therapy. , 1961 .

[307]  Emil Frei,et al.  Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and Methotrexate , 1961 .

[308]  H. Skipper,et al.  Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy. , 1961, Cancer research.

[309]  J. Broome.  Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects , 1961, Nature.

[310]  V. Fairbanks,et al.  Intrathecal administration of amethopterin in leukemic encephalopathy of young adults. , 1961, The New England journal of medicine.

[311]  B. Shnider,et al.  Clinical studies of vinblastine. , 1961, Cancer chemotherapy reports.

[312]  E. Humphrey,et al.  Clinical experience with streptonigrin. , 1961, Cancer chemotherapy reports.

[313]  R. Trussell,et al.  Carcinoma of the cervix treated with continuous intra-arterial methotrexate and intermittent intramuscular leucovorin. , 1961, Lancet.

[314]  K. Kettel.  Treatment of advanced cancer with 5‐fluorouracil , 1961 .

[315]  R. Hume,et al.  Steroid Therapy in Multiple Myeloma , 1961, Scottish medical journal.

[316]  D. Karnofsky,et al.  Clinical observations on the effects of streptonigrin in patients with neoplastic disease. , 1961, Antibiotics & chemotherapy.

[317]  K. Sugiura,et al.  An antitumor spectrum of streptonigrin. , 1961, Antibiotics & chemotherapy.

[318]  I. Toplin,et al.  The effects of streptonigrin on experimental tumors. , 1961, Antibiotics & chemotherapy.

[319]  W. Wilson,et al.  Preliminary observations on the use of streptonigrin as an antitumor agent in human beings. , 1961, Antibiotics & chemotherapy.

[320]  M. Hakala,et al.  Relation of folic acid reductase to amethopterin resistance in cultured mammalian cells. , 1961, The Journal of biological chemistry.

[321]  B. Laurance.  Intracranial Complications of Leukaemia Treated with Intrathecal Amethopterin* , 1961, Archives of disease in childhood.

[322]  E. Frei,et al.  A Study of Prednisone Therapy in Chronic Lymphocytic Leukemia , 1961 .

[323]  D. Pinkel,et al.  Rhabdomyosarcoma in children. , 1961, JAMA.

[324]  D. Galton,et al.  The Use of Chlorambucil and Steroids in the Treatment of Chronic Lymphocytic Leukaemia , 1961, British journal of haematology.

[325]  A. Evans.  Mitomycin C. , 1961, Cancer chemotherapy reports.

[326]  V. Vaitkevicius,et al.  Clinical evaluation of cancer chemotherapy with 5‐fluorouracil , 1961, Cancer.

[327]  G. Woolley,et al.  Transplantable human tumors in experimental chemotherapy: effects of streptonigrin on HS No. 1 and HEp No. 3 in the rat. , 1961, Antibiotics & chemotherapy.

[328]  G. A. Fischer.  Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells. , 1961, Biochemical pharmacology.

[329]  L. Knoepp,et al.  Clinical experience with 5-fluorouracil. , 1961, Cancer chemotherapy reports.

[330]  A. E. Osterberg,et al.  Mitomycin C (NSC-26980)--an evaluation of the Japanese reports. , 1960, Cancer chemotherapy reports.

[331]  W. Wilson.  Chemotherapy of human solid tumors with 5‐fluorouracil , 1960, Cancer.

[332]  S. Gumport,et al.  Remissions produced with the use of Methotrexate in patients with mycosis fungoides. , 1960, Cancer chemotherapy reports.

[333]  C. Frey,et al.  Clinical experience with 5-fluorouracil (NSC-19893) in the treatment of malignant disease. , 1960, Cancer chemotherapy reports.

[334]  G. Moore,et al.  CLINICAL STUDIES OF ACTINOMYCIN D , 1960, Annals of the New York Academy of Sciences.

[335]  W. Krivit,et al.  Use of 5-fluorouracil in the management of advanced maligancies in childhood. , 1960, American journal of diseases of children.

[336]  W. H. Bond,et al.  Vincaleukoblastine. I. Preliminary clinical studies. , 1960, Cancer research.

[337]  R. Noble,et al.  Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease. , 1960, Cancer research.

[338]  M. Lipsett,et al.  Effect of Vincaleukoblastine on metastatic choriocarcinoma and related trophoblastic tumors in women. , 1960, Cancer research.

[339]  Parker Gw,et al.  The clinical evaluation of PA-144(mithramycin) in solid tumors of adults. , 1960 .

[340]  J. Burchenal,et al.  Continuous intraarterial methotrexate with simultaneous, intermittent, intramuscular citrovorum factor herapy in carcinoma of the cervix. , 1960, Cancer chemotherapy reports.

[341]  K. Olson,et al.  Evaluation of 5-fluorouracil in the treatment of cancer. , 1960, Journal of the National Cancer Institute.

[342]  P. Mueller,et al.  The effect of actinomycin D on childhood neoplasms. , 1960, A M A Journal of Diseases of Children.

[343]  J. Burchenal,et al.  The comparison of 6-mercaptopurine with the combination of 6-mercaptopurine and azaserine in the treatment of acute leukemia in children: results of a cooperative study. , 1960, Blood.

[344]  D. Karnofsky,et al.  The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report. , 1960, Cancer chemotherapy reports.

[345]  L. Eliel,et al.  Effects of large infrequent doses of a-methopterin on acute leukemia in children. , 1960, Journal of the American Medical Association.

[346]  R. Yesner,et al.  The Sex Hormones and Cortisone in the Treatment of Inoperable Bronchogenic Carcinoma1 , 1960 .

[347]  J. Vander,et al.  Corticosteroid therapy of chronic lymphocytic leukaemia: a study of erythrocyte survival and leukocyte dynamics. , 1960, Acta - Unio Internationalis Contra Cancrum.

[348]  H. Lemon.  Reduction of 5-fluorouracil toxicity in man with retention of anticancer effects by prolonged intravenous administration in 5 per cent dextrose. , 1960, Cancer chemotherapy reports.

[349]  F. Ansfield,et al.  Mithramycin-human toxicology and preliminary therapeutic investigation. , 1960, Cancer chemotherapy reports.

[350]  J. Burchenal,et al.  Treatment of chronic granulocytic leukemia with the 6-substituted purines 6-mercaptopurine, thioguanine, and 6-chloropurine. , 1960, Clinical pharmacology and therapeutics.

[351]  D. Hammond,et al.  Prednisone in childhood leukemia; comparison of interrupted with continuous therapy. , 1959, Pediatrics.

[352]  R. Winzler,et al.  Metabolism of human leukocytes in vitro. III. Incorporation of formate-C14 into cellular components of leukemic human leukocytes. , 1959, Cancer research.

[353]  J. Burchenal,et al.  The effect of actinomycin D on cancer in childhood. , 1959, Pediatrics.

[354]  R. Jones,et al.  A clinical study of 5-fluorouracil. , 1959, Cancer research.

[355]  R. Silver,et al.  Comparative study of 6-chloropurine and 6-mercaptopurine in acute leukemia in adults. , 1959, Annals of internal medicine.

[356]  D. Lyall,et al.  Chemotherapy of Disseminated Carcinoma of the Breast , 1959, Annals of surgery.

[357]  B. Bouroncle,et al.  Evaluation of the effect of massive prednisolone therapy in acute leukemia. , 1959, Acta haematologica.

[358]  M. Murphy.  Leukemia and Lymphoma in Children , 1959 .

[359]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. VIII. Further biochemical and metabolic investigations. , 1959, The Journal of biological chemistry.

[360]  D. Pinkel.  Actinomycin D in childhood cancer; a preliminary report. , 1959, Pediatrics.

[361]  H. Lemon.  Prednisone therapy of advanced mammary cancer , 1959, Cancer.

[362]  E. Freireich,et al.  A comparative study of two regimens of combination chemotherapy in acute leukemia. , 1958, Blood.

[363]  W. Dameshek,et al.  Treatment of acute leukemia in adults with massive doses of prednisone and prednisolone. , 1958, The New England journal of medicine.

[364]  C. Heidelberger,et al.  Clinical studies with 5-fluorouracil. , 1958, Cancer research.

[365]  H. Marumo,et al.  Isolation of new fractions of antitumor mitomycins. , 1958, Antibiotics & chemotherapy.

[366]  J. Burchenal,et al.  Intrathecal amethopterin in neurological manifestations of leukemia. , 1958, A.M.A. archives of internal medicine.

[367]  S. Taylor,et al.  The use of prednisolone in the treatment of disseminated breast carcinoma , 1958, Cancer.

[368]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. V. Effects on nucleic acid metabolism in vitro. , 1958, Cancer research.

[369]  P. Sturgeon,et al.  6-Mercaptopurine in childhood leukemia; comparison of large dose interrupted with small dose continuous therapy. , 1957, Cancer research.

[370]  M. Pierce.  The acute leukemias of childhood. , 1957, Pediatric clinics of North America.

[371]  S. Taylor,et al.  Treatment of cerebral metastases from breast carcinoma with prednisolone. , 1957, Journal of the American Medical Association.

[372]  C. Heidelberger,et al.  Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds , 1957, Nature.

[373]  H. Ranney,et al.  The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. , 1957, The American journal of medicine.

[374]  W. Best,et al.  Metabolism of human leukocytes in vitro. I. Effects of A-methopterin on formate-C14 incorporation. , 1957, Cancer research.

[375]  P. Sturgeon,et al.  Prednison therapy of acute lymphatic leukemia in children , 1956, Cancer.

[376]  N. Mantel,et al.  Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin. , 1956, Journal of the National Cancer Institute.

[377]  G. Marshall,et al.  MASSIVE PREDNISONE AND PREDNISOLONE THERAPY IN LEUKEMIA AND LYMPHOMAS IN THE ADULT † † , 1956, Journal of the American Geriatrics Society.

[378]  J. Metz,et al.  Chemotherapy of leukaemia. II. 6-Mercaptopurine (purinethol) in the treatment of acute leukaemia and some other neoplastic diseases of the reticuloendothelial system. , 1956, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[379]  W. H. Perry,et al.  Acute leukaemia in adults treated with 6-mercaptopurine. , 1956, Canadian Medical Association journal.

[380]  J. Fountain.  Treatment of chronic myeloid leukaemia with mercaptopurine. , 1956, British medical journal.

[381]  F. Hayhoe.  6-Mercaptopurine in acute leukaemia. , 1955, Lancet.

[382]  K. Dr.,et al.  Negative effect of actinomycin D treatment in three cases of Hodgkin's disease. , 1955 .

[383]  W. M. Cooper,et al.  A CLINICAL STUDY OF 6‐MERCAPTOPURINE , 1954, Annals of the New York Academy of Sciences.

[384]  S. Farber.  SUMMARY OF EXPERIENCE WITH 6‐MERCAPTOPURINE , 1954, Annals of the New York Academy of Sciences.

[385]  T. Feichtmeir,et al.  CLINICAL EXPERIENCE WITH 6‐MERCAPTOPURINE IN HUMAN NEOPLASIA , 1954, Annals of the New York Academy of Sciences.

[386]  R. Rosenthal,et al.  ROLE OF MERCAPTOPURINE IN THE TREATMENT OF LEUKEMIA AND RELATED DISEASES , 1954, Annals of the New York Academy of Sciences.

[387]  M. Pierce.  LEUKEMIA IN CHILDREN: TREATMENT OF 22 CASES WITH 6‐MERCAPTOPURINE , 1954, Annals of the New York Academy of Sciences.

[388]  S. J. Wilson,et al.  THE CLINICAL AND HEMATOLOGIC RESPONSE OF PREVIOUSLY TREATED LEUKEMIC SUBJECTS TO THE ANTIMETABOLITE 6‐MERCAPTOPURINE , 1954, Annals of the New York Academy of Sciences.

[389]  J. Fountain.  CLINICAL OBSERVATIONS OF THE TREATMENT OF LEUKEMIA AND ALLIED DISORDERS WITH 6‐MERCAPTOPURINE , 1954, Annals of the New York Academy of Sciences.

[390]  R. Rundles,et al.  6‐MERCAPTOPURINE THERAPY IN NEOPLASTIC DISEASE , 1954, Annals of the New York Academy of Sciences.

[391]  D. Karnofsky,et al.  CLINICAL STUDIES ON 6‐MERCAPTOPURINE , 1954, Annals of the New York Academy of Sciences.

[392]  J. Wolff,et al.  THE THERAPEUTIC EFFECT OF MERCAPTOPURINE IN A VARIETY OF HUMAN NEOPLASTIC DISEASES , 1954, Annals of the New York Academy of Sciences.

[393]  D. Thompson,et al.  TREATMENT OF LEUKEMIA AND RELATED DISORDERS WITH 6‐MERCAPTOPURINE , 1954, Annals of the New York Academy of Sciences.

[394]  G. Cartwright,et al.  Treatment of acute leukemia with cortisone and corticotropin. , 1954, A.M.A. archives of internal medicine.

[395]  J. G. Kidd.  REGRESSION OF TRANSPLANTED LYMPHOMAS INDUCED IN VIVO BY MEANS OF NORMAL GUINEA PIG SERUM , 1953, The Journal of experimental medicine.

[396]  E. Greenspan,et al.  Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms , 1952, Cancer.

[397]  W. Dameshek,et al.  The use of adrenocorticotropic hormone and cortisone in the treatment of leukemia and leukosarcoma. , 1951, Blood.

[398]  C. P. Rhoads,et al.  The effects of the folic acid antagonists and 2,6‐diaminopurine on neoplastic disease. With special reference to acute leukemia , 1951, Cancer.

[399]  Freedman Mh.  Folic acid antagonists in the treatment of acute and subacute leukemia. , 1951 .

[400]  L. Craver,et al.  A study of the natural history of acute leukemia with special reference to the duration of the disease and the occurrence of remissions , 1951, Cancer.

[401]  M. S. Sacks,et al.  The response of acute leukemia to the administration of the folic acid antagonists, aminopterin and a-methopterin; report of 14 cases. , 1950, Annals of internal medicine.

[402]  W. Dameshek,et al.  The use of folic acid antagonists in the treatment of acute and subacute leukemia. , 1949, Blood.

[403]  T. Dougherty,et al.  An evaluation of alterations produced in lymphoid tissue by pituitary-adrenal cortical secretion. , 1947, The Journal of laboratory and clinical medicine.

[404]  A. White,et al.  INFLUENCE OF HORMONES ON LYMPHOID TISSUE STRUCTURE AND FUNCTION. THE ROLE OF THE PITUITARY ADRENOTROPHIC HORMONE IN THE REGULATION OF THE LYMPHOCYTES AND OTHER CELLULAR ELEMENTS OF THE BLOOD1 , 1944 .

[405]  W. Macfee.  The Treatment of Advanced Cancer of the Breast , 1931 .